COVID-19-adapted addiction services and impact for service users

Insights zone 4 (I4)
In programme
Friday, 25 November, 2022 - 10:50 to 12:20
View presentations

About

The aim of this symposium is to discuss how people who use drugs have been affected by changes in the provision of treatment and harm reduction services during the COVID-19 pandemic.

Chair

Hakkarainen
Pekka
  • Research Professor,
  • Finnish Institute For Health And Welfare (THL),
  • Helsinki,
  • Finland

Type

Tracks

Keywords

Presentations

Friday, 25 November

10:50
Oral presentation

1. Revised service delivery of opioid agonist treatment in Norway in 2021, the second year of the pandemic: a national cross-sectional study of treatment provider experiences

10:50 to 12:20
Insights zone 4 (I4)
Anne Berit Bech
Oral presentation

2. A rapid assessment of take-home naloxone provision during COVID-19 in Europe

10:50 to 12:20
Insights zone 4 (I4)
Rebecca Mc Donald
Oral presentation

3. Will they accept the vaccine? A 2021 COVID-19 survey among 477 people who use drugs in Norway

10:50 to 12:20
Insights zone 4 (I4)
Gabrielle K. Welle-Strand
Oral presentation

4. Have predictors of drug addiction relapse changed during the COVID-19 pandemic? A prospective study of recovery pathways in the Netherlands, Belgium and UK

10:50 to 12:20
Insights zone 4 (I4)
Thomas Martinelli
Oral presentation

5. The impacts of COVID-19 pandemic on drug purchasing behaviours of people who use methamphetamine in Victoria, Melbourne.

10:50 to 12:20
Insights zone 4 (I4)
Kasun Rathnayake
View the programme